PEPTIDE CENTER

PIONEER IN PHARMACEUTICAL AND COSMETIC INDUSTRIES

WHY HUBER?

Peptide Center, as a pioneer in the pharmaceutical and cosmetic industries, offers innovative solutions for peptide production and the application of nano-liposome technology. With groundbreaking advances in high-purity peptide production and the development of its proprietary nano-liposome device, the company is leading the way in pharmaceutical and cosmetic industries. Peptide Center aims to transform the cosmetic and pharmaceutical markets through quality, innovation, and sustainability.

Innovation in Nano-Liposome Technology

Peptide Center’s nano-liposome device represents one of the greatest technological achievements in the pharmaceutical and cosmetic industries. Nano-liposomes, as molecular carriers for active ingredients, deliver peptides more effectively and with enhanced stability to target tissues. This technology is poised to revolutionize targeted therapies and skincare applications.

Key Features of Peptide Center’s Nano-Liposome Technology:

Precision Encapsulation: The technology ensures that peptides are encapsulated with high accuracy, preserving their structure and efficacy.
Enhanced Bioavailability: Nano-liposome technology enables peptides to penetrate biological barriers more effectively, ensuring optimal delivery to target tissues.
Scalability and Efficiency: The innovative design allows for large-scale production with minimal waste, making the technology both cost-effective and environmentally sustainable.

Unmatched Peptide Purity

Peptide Center’s peptide production process achieves an unprecedented level of purity. Peptides are highly valued in the pharmaceutical and cosmetic industries for their therapeutic potential and ability to improve skin health. However, producing them with high purity and stability has always been a challenge.

Highlights of Peptide Center’s Peptide Production Process:

Exceptional Purity Levels: The process ensures that contaminants and byproducts are virtually eliminated, meeting and exceeding the highest pharmaceutical-grade standards.
Superior Stability: Peptides produced with this method exhibit enhanced stability, increasing their shelf life and improving their performance in formulations.
Customizability: The process allows for precise tailoring of peptides to meet specific therapeutic and cosmetic needs.

Peptides are a rapidly growing segment in the global pharmaceutical and cosmetic markets. With increasing demand for advanced anti-aging skincare products and targeted therapies, Peptide Center’s innovation addresses a critical market need. The enhanced bioavailability provided by the nano-liposome technology, combined with the superior purity of peptides, positions Peptide Center as a preferred partner for companies seeking cutting-edge solutions.

History of the Peptide Center Team

The establishment of the Peptide Center is the result of collaboration among a diverse and highly experienced team, each with decades of expertise in pharmaceuticals, biochemistry, peptide synthesis, and business development. This team initially came together through their involvement with the parent companies Peptide Center Darou Gostar and Arman Caspian. Both companies are knowledge-based enterprises with production licenses and various pharmaceutical certifications, and they continue to support the Peptide Center as parent organizations.

The formation of this team reflects their shared vision to revolutionize the cosmetic and pharmaceutical peptide market by offering innovative, sustainable, and science-based solutions. The team members connected through mutual academic and professional networks, particularly in the field of pharmaceutical research and industrial collaborations. By combining their expertise and a shared commitment to innovation and sustainability, they established the specialized Peptide Center department.

The Peptide Center team includes professors, university lecturers, and scientists who rank among the top 1% of researchers globally in their specialized fields. Their deep knowledge and groundbreaking achievements in peptide synthesis, biotechnology, and nanoliposome technology have set new standards in the industry.

Key Members and Their Contributions

Dr. Mohammad Karim Karimi

Medical Doctor (GP)

Chief Executive Officer (CEO)

LinkedIn: mohammad-karim-karimi-6775829

With over 17 years of experience in the health industry, Dr. Karimi has been instrumental in leading Peptide Center since its inception. He has served as the Managing Director and Member of the Board, leveraging his extensive background in pharmaceutical manufacturing and healthcare product development to drive strategic growth and innovation.

Dr. Amir Zeinolabedin Ebrahimi

Medical Doctor

Chief Business Officer (CBO)

LinkedIn: amir-z-ebrahimi-b5233699

Dr. Ebrahimi, a seasoned entrepreneur and expert in business development, joined Peptide Center with a focus on expanding its market reach and building robust client relationships. With a medical degree and additional training in marketing and commerce, he has played a pivotal role as Chairman of the Board, overseeing the company’s strategic direction.

Dr. Mohammadreza Rouini
Professor of Biopharmaceutics and Pharmacokinetics

Chief Scientific Officer (CSO)

LinkedIn: mohammad-reza-rouini-084a6138

A distinguished professor with over 29 years of experience in biopharmaceutics and pharmacokinetics, Dr. Rouini has significantly contributed to the scientific foundation of Peptide Center. As a member of the board and shareholder, he provides invaluable insights into advanced peptide delivery mechanisms and pharmaceutical compounding.

Dr. Sorour Ramezanpour

Ph.D. Organic Chemistry

Head of Research and Development (R&D Lead)

LinkedIn: sorour-ramezanpour-60b06438

Specializing in peptide synthesis, Dr. Ramezanpour heads the Research & Development department at Peptide Center. Her extensive academic and industrial background in synthesizing active pharmaceutical ingredients and peptides ensures the development of high-purity and effective cosmetic peptides.

Dr. Hamed Hamishehkar

Ph.D., Pharmaceutics

Chief Technology Officer (CTO) and Ownership

https://scholar.google.com/citations?user=le6cgp4AAAAJ&hl=en&oi=ao

With over 20 years of experience in the formulation of pharmaceutical dosage forms and expertise in nano-encapsulation and dermal drug delivery systems, Dr. Hamishehkar serves as a Senior Advisor to the company. His guidance has been pivotal in integrating advanced technologies, such as nano-liposome systems, into Peptide Center’s product offerings.

Euronada LLC. Co

Accelerator Company

Strategic Partner and Growth Accelerator

https://www.linkedin.com/in/Euronada

https://www.euronada.ca

Euronada, is a globally recognized accelerator and business development company specializing in strategic consulting, market evaluation, investment attraction, and startup ecosystem enhancement. With a proven track record of supporting over 20 innovative startups and building a strong network of investors, universities, and research institutions, Euronada is committed to empowering entrepreneurs to bring transformative ideas to market. By providing tailored solutions, Euronada ensures startups navigate market complexities, secure funding, and achieve sustainable growth.

Role in Peptide Center

Strategic Partner and Growth Accelerator
In its partnership with Peptide Center, Euronada plays a pivotal role in:

Strategic Management of Projects: Streamlining Peptide Center’s innovative initiatives by offering in-depth market analysis, operational guidance, and business model refinement.
Investment Attraction: Leveraging its extensive investor network to secure funding for Peptide Center’s cutting-edge cosmetic peptide products.
Market Development: Facilitating Peptide Center’s entry into new international markets, particularly in Europe and North America, through robust networking and market penetration strategies.
Regulatory and Intellectual Property Support: Assisting Peptide Center in acquiring necessary certifications, navigating regulatory requirements, and registering patents for its proprietary technologies.
Mentorship and Networking: Connecting Peptide Center with leading academic institutions and R&D centers to foster collaborations and promote innovation.

By integrating its expertise and resources, Euronada aims to accelerate Peptide Center’s journey toward becoming a global leader in the cosmetic peptide industry.

Why Choose Peptide Center?

Scientific Innovation: Peptide Center is at the forefront of scientific development, particularly in nano-liposome technology and high-purity peptide production.
Sustainability and Efficiency: Peptide Center’s products not only perform at a global level but are also produced through sustainable processes.
Global Impact: With its technologies, Peptide Center is ready to make a profound impact in global pharmaceutical and cosmetic markets.

With unparalleled innovations and a commitment to quality and sustainability, Peptide Center is positioned to lead the future of the pharmaceutical and cosmetic industries, delivering remarkable value to its stakeholders.

“We are focused on delivering excellence in some peptide designs, synthesis at small-scale and large scale, as well as GMP manufacturer of these peptides for customers. We can offer a full end-to-end peptide service in these API’s:”

Glatiramer acetate
Cetrorelix
Ganirelix
GHK-Cu

Our suggestion for Value-Enhancing Initiatives in cosmetic and pharmaceuticals peptides

The “Peptide Center” project, utilizing advanced nanoliposomal technology, offers significant advantages in the fields of pharmaceuticals, therapeutics, and cosmetics. This innovative technology, through the use of nanoliposomes, can dramatically enhance the efficacy of products in both therapeutic and cosmetic sectors, positioning it as a unique competitive advantage in the market. These advantages include:

Increased Bioavailability

By utilizing nanoliposomes, peptides in the “Peptide Center” project are more effectively transported to cells and tissues, significantly enhancing their absorption in the body. This feature can substantially improve the therapeutic effectiveness of products and, in cosmetic products, contribute to better and faster absorption of active ingredients.

Higher Stability Against Degradation and Corruption

Nanoliposomes protect peptides from degradation in various environments (such as the digestive system or exposure to light). This property increases the shelf life and long-term efficacy of “Peptide Center” products, leading to more durable and effective products in both pharmaceutical and cosmetic applications.

Targeted Drug Delivery

Nanoliposomes enable targeted delivery of peptides to specific tissues and cells, such as cancer cells or damaged tissues. This feature allows for more specialized and precise treatments in the “Peptide Center” project, which can reduce side effects and enhance therapeutic effectiveness.

Reduction of Side Effects

The use of nanoliposomes helps in more precise drug delivery, which can reduce side effects of “Peptide Center” products and increase therapeutic efficacy. This advantage could lead to higher patient and consumer satisfaction.

Improved Skin Penetration

In the skincare products of “Peptide Center,” nanoliposomes allow peptides to penetrate deeper into the skin. This feature enhances the anti-aging, moisturizing, and healing effects of products, improving skin appearance and health.

Controlled Release of Active Ingredients

With the aid of nanoliposomes, the release of active ingredients in “Peptide Center” products occurs in a controlled manner. This allows for the development of products with more stable and prolonged therapeutic effects, which can be beneficial for chronic treatments or specific needs.

Wide Application Potential

This technology can be utilized in various industries, including pharmaceuticals, skincare, nutritional supplements, and targeted therapies. The “Peptide Center” project, with this feature, can be recognized as a comprehensive solution across different industries, offering a wide range of applications.

Compatibility with Various Materials and Compounds

Nanoliposomes can be combined with various peptides and other active ingredients. This property enables the “Peptide Center” project to produce a diverse range of effective products for various markets, which can be beneficial for both pharmaceutical and cosmetic industries.

Customization Potential

The Nano liposomal formulation process in the “Peptide Center” project allows for precise adjustment of various properties, such as particle size, electrical charge, and peptide coating levels. This enables the production of products with specific characteristics tailored to unique therapeutic or application needs, whether for pharmaceutical use or skincare products.

Enhanced Therapeutic Effectiveness

The improved absorption and more precise targeting of peptides via nanoliposomes result in more effective treatments in the “Peptide Center” project. This feature can lead to greater customer and consumer satisfaction and better therapeutic outcomes.

Nano capsulation and Active Ingredient Delivery

Nano capsulation, using nano liposomal technology, helps deliver active ingredients efficiently within the body and skin. This process can be applied for using drugs, peptides, and various chemicals in specialized treatments and cosmetic products.

Conclusion

The “Peptide Center” project, by leveraging these unique competitive advantages, can provide an advanced and innovative solution in the pharmaceutical and cosmetic sectors and establish itself as a market leader. These features and benefits can lead to the creation of high-efficacy products with better stability and fewer side effects, ultimately aiding in the development of new markets and attracting more customers.

Liposome

Enhanced Bioavailability

Nanoliposome

Liposomes are spherical vesicles and consist of a lipid bilayer that mimics the cell membrane. Liposomes can encapsulate both hydrophilic and hydrophobic natural extracts, making them versatile carriers.

Nanoliposomes play a significant role in the cosmetic industry, particularly in the delivery of peptides. Nanoliposomes offer a promising delivery platform for cosmetic peptides, providing enhanced stability, improved penetration, controlled release, targeted delivery, and biocompatibility. By harnessing the advantages of nanoliposomes, cosmetic companies can develop innovative formulations that maximize the efficacy of peptides and deliver superior skincare benefits to consumers.

History of liposomes in cosmetics:

The first liposomal cosmetic product introduced into the commercial market was the Capture anti-aging cream by firm Christian Dior in 1986, which has been followed by many other products.
In the field of skin care, Laboratories RoC launched 2 products in 1987 and 1990 that were Myosphere, the first emulsion with inclusion of liposomes and the first liposomal facial cream for men.
For body care, the first liposomal formulation was introduced in 1987, and many other products, the majority of which claimed to be effective for slimming, were manufactured after that. In 1988 and later, other skin protectives such as sunscreens or self-tanning products were also turned out.
The first product containing liposomes for make-up was a powder produced in 1988, followed by mascara and different foundations.

ANTI-AGING PEPTIDES

↑ Molecular weight
↓ Lipid permeability
Enzyme substrate

NANOENCAPSULATION OF ANTI-AGING PEPTIDES

(Nanoliposome, Niosome, Nanosphere)

Sustained peptide release
↑ Peptide stability
↑ Skin penetration
↑ Contact surface area

IMPROVED COSMETIC EFFECTS

↑ Skin thickness and firmness
↑ Skin texture and elasticity
↓ Wrinkles
Depigmentating effect

Peptides and Nanoliposomes in Pharmaceutical Applications

Therapeutic Peptides

Increased molecular weight
Reduced permeability through biological membranes
Susceptibility to enzymatic degradation

Nanoencapsulation of Therapeutic Peptides

(Nanoliposome, Nanosphere, Niosome)

Enhanced peptide stability in the body
Controlled and targeted drug release
Increased bioavailability and tissue penetration
Improved drug distribution in the body

Improved Effects in Drug Therapies

Enhanced therapeutic efficacy and reduced dosage
Minimized drug side effects
Increased half-life of peptides in circulation
Optimized drug delivery to target tissues

Our Services

Peptide Center operates on a multi-faceted B2B business model, ensuring scalability, profitability, and long-term industry impact.

Direct Sales Model: Supplying high-purity peptide ingredients directly to cosmetic companies.
Licensing Model: Licensing nano-liposome encapsulation technology to skincare brands and manufacturers.
R&D and Collaborative Development: Partnering with cosmetic labs and premium brands to co-develop specialized peptide formulations.
Subscription-Based Peptide Supply Model: Providing long-term, recurring supply contracts for brands seeking consistent peptide sourcing.

Viability Analysis

Peptide Center addresses critical challenges in the cosmetics and pharmaceutical industries by leveraging its innovative Nano liposome technology and commitment to sustainability. With the increasing global demand for effective, eco- friendly products, the company is well positioned to establish itself as a leader in peptide-based solutions. This viability analysis explores the key factors that contribute to its strong foundation for sustainable growth and long- term success.

Value Proposition

Peptide Center delivers innovative, high-purity peptide solutions enhanced by its patented Nano liposome technology. By addressing the dual challenges of sustainability and efficacy, the company provides eco-friendly, scientifically validated products that meet the growing demand for personalized solutions in the cosmetics industry. With plans to expand into pharmaceuticals in the future, Peptide Center’s unique combination of advanced technology, customization, and ethical practices positions it as a trusted and forward-thinking partner for businesses globally.

Market Potential

The global peptide market is experiencing significant growth, driven by increasing consumer demand for sustainable and high-performance products. The cosmetic peptide market, in particular, is expected to expand rapidly as eco-conscious consumers prioritize scientifically proven, results-driven solutions. Peptide Center is strategically positioned to capitalize on these trends with its advanced peptide formulations, offering a strong entry point into premium and niche markets. While cosmetics remain its current focus, the planned entry into pharmaceuticals in the coming years significantly broadens its long-term revenue potential.

Scalability

Peptide Center’s modular production system ensures efficient scaling to meet increasing market demands. Starting with pilot batches, the company can seamlessly transition to full-scale manufacturing while maintaining product quality and cost efficiency. This scalability allows Peptide Center to adapt to the evolving needs of its clients and support rapid market expansion without compromising operational integrity.

Strategic Location

Operating from Finland, Peptide Center capitalizes on the country’s robust regulatory framework, advanced infrastructure, and strong government support for biotechnology and sustainability-focused startups. Finland’s strategic location provides seamless access to European and global markets, enabling efficient distribution and collaboration with international clients. Renowned for its innovation ecosystem, Finland offers access to a skilled workforce, cutting-edge research facilities, and significant funding opportunities through programs like Business Finland. Additionally, the country’s leadership in sustainability aligns perfectly with Peptide Center’s mission, reinforcing its credibility in delivering eco- conscious solutions. This strategic base positions Peptide Center to thrive in a competitive landscape while scaling its business globally.

Cost Management

While Peptide Center faces high initial costs for R&D, regulatory compliance, and production setup, its streamlined operations and modular production system mitigate long-term expenses. The company’s focus on sustainability further reduces waste and optimizes resources, ensuring efficient cost management. As production scales, the per-unit cost decreases, boosting profitability and financial sustainability.

Competitive Advantage

Peptide Center’s patented Nano liposome technology provides a distinct edge over competitors, enhancing the efficacy and stability of its peptide-based products. Unlike many competitors, Peptide Center combines advanced science with sustainability, creating a unique offering that resonates with eco-conscious businesses and consumers. Its ability to deliver customized solutions tailored to specific client needs ensures strong competitiveness in the cosmetics market. The planned expansion into pharmaceuticals adds a promising dimension for future growth.

QUESTIONS & INQUIRIES

For any questions, inquiries, curiosities, please contact us! We will be pleased to talk to you anytime